coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Hyde PCN, Tameside (LAD) · Health Inequalities Profile

    PCN U02275 · NHS Greater Manchester Integrated Care Board · 8 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    73,240

    Registered population

    61.1% aged 18–64

    18.1%

    Aged 65+

    ICB 14.9% · England 17.9%

    47.6%

    In IMD quintile 1

    ICB 40.7% · England 21.0%

    ~35,086

    Core20 residents (est.)

    Resident basis; registered basis ~34,826 · see page 3

    12,880

    Hypertension register

    +3.84% in 3 yrs · England +5.60%

    824

    SMI register

    35% of Tameside (LAD)'s

    2,462

    COPD register

    Reviews -7.29% in 3 yrs

    Forecast to 2030

    14,418

    Hypertension patients, 2030

    +1,538 on today

    66.8%

    QRISK ≥20% on statins, 2030

    -0.01pp over 3 yrs

    4.9%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    62.5%
    Respiratory annual reviews fall behind national trends.

    Asthma reviews fell 3.5% to 62.5% (leaving about 2,100 unreviewed) and COPD reviews fell 7.3% to 70.0%, which may reflect recall capacity limits.

    76.0%
    SMI physical health checks trail England.

    SMI BMI recording fell 1.7 pp to 76.0% (England +5.1 pp) and BP recording is 81.7% (England 83.4%), which could reflect fragmented recall.

    91.0%
    Recent blood pressure recording exceeds benchmarks.

    Recent hypertension BP recording rose 5.7% to 91.0% (England 90.0%, Tameside 89.2%), with 82.6% control at age 80+ (England 81.2%).

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    Hyde PCN serves 73,240 patients with an older age profile than the ICB

    Hyde PCN cares for 73,240 registered patients across eight practices. Patients aged 65+ represent 18.1% of the list (13,265 patients; Tameside 16.4%, NHS Greater Manchester ICB 14.9%, England 17.9%). Children aged 0–17 make up 20.8% (15,207 patients; Tameside 21.3%, ICB 21.8%, England 19.6%), and 61.1% are aged 18–64 (44,768 patients; Tameside 62.3%, ICB 63.3%, England 62.7%). Census resident estimates record 0.1% Gypsy or Irish Traveller and 0.0% Roma. Projected list growth to 2030 is 1.9% (Tameside 1.4%, ICB 1.6%, England 2.3%) under unverified methodology.

    Age profile

    0–1720.8%
    18–6461.1%
    65+18.1%

    65+: ICB 14.9%, England 17.9%

    Older people · falls rows are Tameside (LAD) local-authority (LA) data, not PCN

    MeasureLocalNorth WestEnglandPeriod
    Falls admissions, 65+, per 100,000 (Tameside LA)2,0472,0711,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)84.8%82.9%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)56.7%56.6%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Tameside LA)1,0451,0219552024/25
    Falls deaths, all ages, per 100,000 (Tameside LA)32.518.214.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Core20 deprivation affects 47.6% of patients, spanning a 96.0 percentage point practice range

    Across Hyde PCN, 47.6% of registered patients live in Core20 areas, above Tameside (40.9%), the ICB (40.7%) and England (21.0%), with an average IMD decile of 3.7 (England 5.5). Resident Core20 estimates total 35,086, while practice estimates sum to 34,826. Core20 share spans 96.0 pp across practices: Hattersley Group Practice records 96.0%, whereas The Smithy Surgery records 0.0%. In contrast, volume concentrates at The Brooke Surgery (10,255 estimated patients) and Haughton Thornley Medical Centres (6,680). Interventions could balance intensive practice targeting with PCN-wide cohort capacity.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Hattersley96.0% · 4,706 patients
    Clarendon53.0% · 3,548 patients
    Haughton Thornley53.0% · 6,680 patients
    Donneybrook52.9% · 4,138 patients
    Brooke50.7% · 10,255 patients
    Dukinfield34.4% · 3,850 patients
    Awburn House26.9% · 1,649 patients
    Smithy0.0% · 0 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    824

    SMI register

    1.11% recorded prevalence

    528

    Learning disability register

    0.71% recorded prevalence

    16

    Care homes, 683 beds

    In the PCN catchment

    9.7%

    Provide unpaid care

    Tameside (LAD), Census 2021

    Recorded severe mental illness prevalence is 1.1% (824 patients; Tameside 1.0%, ICB 1.1%, England 1.0%), and learning disability prevalence is 0.7% (528 patients; Tameside 0.7%, ICB 0.6%, England 0.6%). Catchment care homes total 16 sites with 683 beds, though resident registrations are unconfirmed.

    Severe mental illness: physical health checks

    Severe mental illness prevalence is 1.1% (England 1.0%). Over 2023 to 2025, annual BMI recording fell 1.7 pp to 76.0% (England +5.1 pp to 82.1%), alongside BP checks at 81.7% (England 83.4%).

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    12,880

    Hypertension register

    +3.84%

    Register growth, 3 yrs

    Tameside (LAD) +5.50% · England +5.60%

    +3.24pp

    BP control, under 80

    ≤140/90 · +3.10pp aged 80+

    +1,538

    More patients by 2030

    Forecast 14,418 (18.77%)

    Hypertension case-finding and control

    Hypertension prevalence is 17.4% (12,880 patients), matching Tameside (17.4%) and above England (15.2%) and NHS Greater Manchester ICB (14.4%). Recent blood pressure recording reached 91.0%, above England (90.0%) and the ICB (90.3%). However, blood pressure control for patients aged under 80 is 67.0%, below England (67.8%) and the ICB (68.6%), while control at age 80+ reached 82.6% (England 81.2%). Denominators include personalised care adjustments, and observation periods are unconfirmed. Under-80 blood pressure control trails ICB and national benchmarks despite high monitoring rates, which may indicate medication titration or adherence gaps, testable by clinical audit.

    Lipids and statins

    For patients with QRISK ≥ 20%, lipid-lowering therapy uptake is 66.8% (England 63.6%, ICB 67.0%), but three-year change was -0.01% over 2023 to 2025 (England +6.2%). Stagnating uptake could reflect treatment-escalation gaps, testable via clinical audit.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 2026152,376£2.00£1.94£1.86£304,752
    Cardiovascular (all), 2025215,510£3.09£3.15£3.33£665,926

    Lipid-regulating drugs cost £2.00 per item across 152,376 items in 2026, compared with £1.86 in England, £1.94 in the ICB, and £2.01 in Tameside. Hyde PCN spends £21,333 more than at England's unit cost. This unit-cost indicator does not reflect prescribing efficiency or formulary appropriateness.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    −3.45%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    +1.31%

    Asthma prevalence, PCN 3-yr % change

    Recorded prevalence exceeds England for COPD (3.3%, 2,462 patients vs 1.9%) and asthma (8.2%, 5,714 patients vs 6.6%), alongside youth asthma prescribing (2,455 items per 1,000 aged 5–19 vs England 1,488). Over 2023 to 2025, COPD reviews fell 7.3% to 70.0% (England +2.8% to 76.4%) and asthma reviews fell 3.5% to 62.5% (England +4.4% to 65.7%), leaving about 2,100 unreviewed asthma patients. Falling reviews could reflect recall capacity constraints, unverified locally.

    Cancer register and children's immunisation

    Cancer register prevalence is 4.1% (3,032 patients; England 3.8%). In Q1 2025/26 childhood immunisations, 24-month 6-in-1 coverage reached 95.8% (England 92.2%). At age 5, coverage drops: MMR2 is 81.7% (11.2 pp below MMR1 at 92.9%, and 13.3 pp below the 95.0% target) and the 4-in-1 booster is 75.1% (England 80.9%). Strong infant uptake is not sustained into pre-school boosters.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months93.0%

    England 91.0%

    6-in-1 complete primary course at 24 months95.8%

    England 92.2%

    MMR dose 1 at 24 months89.1%

    England 88.3%

    MMR dose 2 at age 581.7%

    England 82.8%

    4-in-1 pre-school booster at age 575.1%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    55.6%

    Greater Manchester ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~2,270

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Greater Manchester ICBEnglandNo usable stageStaged cancers
    Lung40.4%33.8%15%2,193
    Prostate61.7%53.2%14%1,788
    Breast82.5%85.4%19%1,758
    Bowel46.3%47.0%19%1,427
    Skin cancer84.5%87.8%27%580

    Cancer stage is published at ICB level, not at PCN level. In 2022, NHS Greater Manchester ICB recorded 55.6% of cancers diagnosed at stage 1 or 2 among cases with a known stage (6,491 of 11,679; England 55.3%), sitting 19.4 pp below the 75.0% national ambition by 2028, while 70.8% had a known stage (11,679 of 16,492). Closing this ICB gap would require about 2,270 extra early diagnoses annually. Within Hyde PCN, cervical screening (25-49) fell 3.2% over 2023 to 2025 (England -1.0%) to 67.8%, with 63.2% at Hattersley Group Practice. Proactive recall may improve screening uptake in practices where coverage trails the PCN average.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    Wait times describe trust and ICB performance, not PCN level. For urgent cancer pathways, Tameside and Glossop Integrated Care NHS Foundation Trust achieved 7.5 pp above the 75.0% 28-day faster diagnosis standard and 0.2 pp above the 96.0% 31-day combined treatment standard. However, on the 62-day referral to treatment standard (85.0%), the trust was 8.2 pp below standard. Across NHS Greater Manchester Integrated Care Board, the 62-day standard was 9.3 pp below standard, while the 28-day standard was 4.5 pp above standard.

    Pathways within standard (%)Tameside and Glossop Integrated CareStockportManchesterGreater Manchester ICBEngland
    28-day faster diagnosis (75%)82.4883.2180.0679.5379.32
    31-day treatment (96%)96.2597.3992.5496.4992.50
    62-day referral to treatment (85%)76.7774.6772.8575.7371.16
    Diagnostic waits over 6 weeks (%)Tameside and Glossop Integrated CareStockportManchesterEngland
    MRI0.001.4111.6821.40
    CT0.182.9314.669.92
    Echocardiography0.0017.464.9128.48
    Colonoscopy1.515.534.5130.83
    Gastroscopy5.455.3129.3529.02
    All 15 DM01 tests0.8014.088.9823.14
    Community services activityTameside residentsGreater Manchester ICB
    Care contacts50,685573,310
    Referrals9,45094,470
    Patients with a contact15,790183,535

    Community services (residents of Tameside), Jun 2026 (provisional). In June 2026 (provisional), community services recorded 50,685 contacts for Tameside residents, of which 26,410 (52.1%) were with adults aged 65 and over. These borough-level data describe wider community caseloads and are not published at PCN level.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Practice variation and patient experience

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Awburn House10826.987.1%71.4%93.0%
    Donneybrook10652.951.1%78.6%79.4%
    Haughton Thornley10253.062.4%54.2%78.6%
    The Smithy Surgery1050.063.4%62.0%75.9%
    Clarendon9753.044.3%75.3%75.6%
    Dukinfield11534.468.0%64.3%75.5%
    The Brooke Surgery9050.745.5%56.8%64.4%
    Hattersley9696.036.5%78.5%49.6%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNTameside (LAD)AssetPCNTameside (LAD)
    Care homes (catchment)16 (683 beds)n/aSchools (catchment)83n/a
    Children's centres716Places of worship47104
    Libraries27Homelessness support (VCS)22
    Primary schools (LA maintained)1022Primary academies2546

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Structured respiratory annual review recall

    Asthma reviews are 62.5% of 5,714 patients (England 65.7%, ICB 66.2%), down 3.5% over 2023 to 2025, leaving about 2,100 (2,142) unreviewed; COPD reviews fell 7.3% to 70.0% of 2,462 (England 76.4%). Moderate effort to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 2

    Bundled SMI physical health checks

    Across 824 SMI patients (1.1% prevalence; 35% of Tameside's register), BMI recording is 76.0% (England 82.1%, ICB 82.9%; -6.1 pp vs England), with a 3-year change of -1.7 pp over 2023 to 2025 (England +5.1 pp), alcohol at 78.1% and BP at 81.7%. Moderate effort to run.

    Evidence base: the SMI register is the cohort for the annual physical health check; the alcohol record is the delivery measure for alcohol screening and brief intervention.

    Policy anchor: Mental Health Investment Standard; NHS alcohol care teams and the From Harm to Hope strategy.

    Option 3

    Age-five booster and MMR2 catch-up

    In Q1 2025/26 (cohort 197), age-5 4-in-1 coverage is 75.1% (England 80.9%), 19.9 pp below the 95.0% target; MMR2 is 81.7%, 11.2 pp below MMR1 (92.9%), with 19.7 pp gap at The Brooke Surgery. Low cost, quick to run.

    Evidence base: coverage against the 95% target is the direct measure of programme delivery and catch-up need; where coverage clusters low, that decides whether catch-up is organised at practice, PCN, school or outreach level.

    Policy anchor: 10 Year Health Plan, shift from sickness to prevention.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Older adult frailty capacity planning (p2)Aged 65+Neighbourhood health framework · NHS vaccination strategyPCN
    Targeted Core20 resource allocation (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    SMI physical check template audit (p4)SMI register with a BMI recorded in the last 12 monthsMHIS · From Harm to HopePCN
    Hypertension blood pressure control review (p5)Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Pre-school booster catch-up (p6)4-in-1 pre-school booster (DTaP/IPV) coverage at age 510YHP sickness to prevention · 95% targetPCN
    Cervical screening recall review (p7)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026PCN
    Telephony and triage review (p9)GPPS easy to contact the practice by phone10YHP, hospital to communityPractice
    Option 1 · Structured respiratory annual review recall (p12)Asthma register · Asthma: QOF prevalence · Patients with Asthma: review in the last 12 months (denominator incl. PCAs)Core20PLUS5 respiratoryPCN
    Option 2 · Bundled SMI physical health checks (p12)Severe mental illness register · Severe mental illness: QOF prevalence · SMI register with a BMI recorded in the last 12 monthsMHIS · From Harm to HopePCN
    Option 3 · Age-five booster and MMR2 catch-up (p12)4-in-1 pre-school booster (DTaP/IPV) coverage at age 5 · MMR dose 2 coverage at age 5 · MMR dose 1 coverage at age 510YHP sickness to prevention · 95% targetPCN
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026Local authority2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15